MedPal AI (MPAL) investor relations material

Trading performance

• New Health revenue was £3.63m in October, up 33% from £2.73m in September, across 29,450 orders.

• Group revenue was ~£4.1m, up from ~£3.2m in September; annualised October run rate was over £49m, a pro forma calculation and not a forecast.

• NHS prescriptions and eMARX subscriptions contributed ~£0.5m of October revenue.

Repeat orders and customers

• New Health repeat order revenue more than doubled to £1.34m in October, 37% of New Health revenue, versus £0.63m and 23% in September; August revenue was ~£0.1m.

• Repeat orders were received from 46% of customers whose 28-day reorder fell due in October; repeat orders had ~23% higher average order value than first orders and no acquisition cost.

• Repeat orders and recurring subscriptions generated ~£1.8m, 45% of Group October revenue, up from ~33% in September.

• New Health served almost 20,000 new customers in October and over 53,000 since marketing began in July; this equated to ~2.7% of the cited estimate of 2m UK GLP-1 weight-management users.

Operations and technology

• New Health customer services and prescribing moved to seven days a week; pharmacy dispensing operates six days a week, with Sunday delivery added.

• Juno sent 91% of New Health WhatsApp replies in October, with 85% of conversations handled without human involvement.